The Latest Headlines at American Banking and Market News
Keyera (TSE:KEY) Price Target Increased to C$39.00 by Analysts at Jefferies Financial Group
Keyera (TSE:KEY – Get Free Report) had its price target boosted by equities research analysts at Jefferies Financial Group from C$38.00 to C$39.00 in a research note issued on Wednesday, BayStreet.CA reports. The brokerage currently... More of this article »
KP Tissue (TSE:KPT) Price Target Cut to C$10.00 by Analysts at Desjardins
KP Tissue (TSE:KPT – Get Free Report) had its price objective cut by Desjardins from C$11.00 to C$10.00 in a report released on Wednesday, BayStreet.CA reports. The firm presently has a “hold” rating on the stock.... More of this article »
National Bankshares Increases Keyera (TSE:KEY) Price Target to C$35.00
Keyera (TSE:KEY – Get Free Report) had its target price lifted by equities research analysts at National Bankshares from C$34.00 to C$35.00 in a report issued on Wednesday, BayStreet.CA reports. National Bankshares’ price... More of this article »
Delcath Systems, Inc. (NASDAQ:DCTH) Receives $18.50 Average Price Target from Analysts
Delcath Systems, Inc. (NASDAQ:DCTH – Get Free Report) has received an average rating of “Buy” from the five brokerages that are currently covering the firm, MarketBeat reports. Five analysts have rated the stock... More of this article »
TD Securities Cuts KP Tissue (TSE:KPT) Price Target to C$8.50
KP Tissue (TSE:KPT – Get Free Report) had its price objective cut by analysts at TD Securities from C$9.00 to C$8.50 in a report issued on Wednesday, BayStreet.CA reports. The firm presently has a “hold” rating on... More of this article »
Brokerages Set Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) Price Target at $18.14
Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM – Get Free Report) has received a consensus rating of “Reduce” from the eight analysts that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock... More of this article »
Hamilton Insurance Group, Ltd. (NYSE:HG) Receives $19.80 Average PT from Brokerages
Hamilton Insurance Group, Ltd. (NYSE:HG – Get Free Report) has been given an average rating of “Buy” by the six brokerages that are presently covering the company, Marketbeat reports. Six equities research analysts... More of this article »
Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX) Given Consensus Recommendation of “Buy” by Analysts
Shares of Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX – Get Free Report) have earned an average rating of “Buy” from the six analysts that are currently covering the stock, MarketBeat.com reports. Six research... More of this article »
Keyera (TSE:KEY) Price Target Raised to C$38.00 at BMO Capital Markets
Keyera (TSE:KEY – Get Free Report) had its price target increased by investment analysts at BMO Capital Markets from C$36.00 to C$38.00 in a report issued on Wednesday, BayStreet.CA reports. The firm presently has an “outperform”... More of this article »
Keyera (TSE:KEY) PT Raised to C$40.00 at Stifel Nicolaus
Keyera (TSE:KEY – Get Free Report) had its price objective lifted by stock analysts at Stifel Nicolaus from C$39.00 to C$40.00 in a research report issued on Wednesday, BayStreet.CA reports. The brokerage currently has a “buy”... More of this article »
Elevation Oncology, Inc. (NASDAQ:ELEV) Receives $7.40 Average Target Price from Analysts
Elevation Oncology, Inc. (NASDAQ:ELEV – Get Free Report) has been assigned a consensus rating of “Buy” from the six analysts that are presently covering the stock, MarketBeat reports. Six equities research analysts... More of this article »
Aspen Technology, Inc. (NASDAQ:AZPN) Receives $201.00 Average Target Price from Analysts
Shares of Aspen Technology, Inc. (NASDAQ:AZPN – Get Free Report) have been assigned an average rating of “Hold” from the five brokerages that are presently covering the firm, Marketbeat.com reports. Three research... More of this article »
Analysts Set Vermilion Energy Inc. (NYSE:VET) PT at $25.00
Shares of Vermilion Energy Inc. (NYSE:VET – Get Free Report) (TSE:VET) have received an average rating of “Moderate Buy” from the five research firms that are currently covering the company, MarketBeat Ratings reports.... More of this article »